We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
11 hedge funds and large institutions have $47.6M invested in Zealand Pharma A/S American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
44% more capital invested
Capital invested by funds: $33M → $47.6M (+$14.5M)
15% less funds holding
Funds holding: 13 → 11 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$730K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$788K |
| 2 |
Jane Street
New York
|
-$320K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$203K |
| 4 |
Morgan Stanley
New York
|
-$16.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.71K |